about
Posttransplant lymphoproliferative disease after pediatric solid organ transplantationClassical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor.Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases.Malignancies after pediatric kidney transplantation: more than PTLD?Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequenciesEarly and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation: Summary of an ESPGHAN Monothematic Conference.Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms.Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation.Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation.Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT.MicroRNA expression in Epstein-Barr virus-associated post-transplant smooth muscle tumours is related to leiomyomatous phenotype.Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program.Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.Posttransplant lymphoproliferative disorder in pediatric patients.Epstein-Barr virus-associated smooth muscle tumours after transplantation, infection with human immunodeficiency virus and congenital immunodeficiency syndromes.
P50
Q26866013-5C7CDC35-DE23-4582-940F-92D819CE2CD3Q30313852-93130BAD-283A-4B69-AC92-04818496F6F0Q35063668-A6BB064F-A1EC-40F2-9701-5B8DFC123E7EQ35104509-9F2809BD-61B7-4C62-B179-153A3AE674E8Q37322142-4596D97D-86A7-4099-A2C1-36747A3567EBQ38072267-4109D42E-8315-4DDD-8383-21D9F971D291Q38141838-C63CED34-2E2B-4206-A3BC-8B5736DB62D5Q39156328-C4E5A546-4AA7-4897-86E4-893CCD76630DQ40287794-CE231DE6-A97A-48CB-A8BB-275C825325EFQ40504861-E437DDDE-7466-414D-BC46-A38D146A1606Q40765516-D4BCDB55-52F3-46E8-81C0-7F945594AE08Q40859295-E4E64EC6-372F-441D-8A1C-4313B65175D1Q41524284-449B8F82-FF86-4377-B1EA-68C1583D0C0BQ42207091-4F5025B4-529C-4AF3-BB53-62FA217A2CB2Q42213088-A0646811-C69A-4B72-AA16-27BFF5D818A9Q42253513-24A06799-F712-4856-A202-A85DAFB0C5C8Q42271011-D2B519F5-6B1F-4C89-AB0B-6C75B18BF69EQ42271431-BA1D337A-CBCA-4E5A-93DA-794D3C084E2DQ42271499-D874DE1F-0288-4B0C-8FA6-DC98E3057FA0
P50
name
Britta Maecker-Kolhoff
@ast
Britta Maecker-Kolhoff
@en
Britta Maecker-Kolhoff
@es
Britta Maecker-Kolhoff
@fr
Britta Maecker-Kolhoff
@nl
type
label
Britta Maecker-Kolhoff
@ast
Britta Maecker-Kolhoff
@en
Britta Maecker-Kolhoff
@es
Britta Maecker-Kolhoff
@fr
Britta Maecker-Kolhoff
@nl
prefLabel
Britta Maecker-Kolhoff
@ast
Britta Maecker-Kolhoff
@en
Britta Maecker-Kolhoff
@es
Britta Maecker-Kolhoff
@fr
Britta Maecker-Kolhoff
@nl